Today

Upexi completed a $100 million private placement of common stock and pre-funded warrants, alongside issuing additional warrants to an asset manager, significantly increasing potential share dilution.

TransCode Therapeutics shareholders approved the issuance of common stock upon warrant exercise, including price adjustments and a cashless exercise feature, which could lead to significant future dilution.

TransCode Therapeutics shareholders will vote on a proposal to adjourn the special meeting if needed to solicit more proxies for another proposal.

Third Coast Bancshares shareholders approved the issuance of common stock required for its merger with Keystone Bancshares, Inc.

Lyra Therapeutics' stockholders approved a reverse stock split, which the Board then set at a 1-for-50 ratio, effective May 27, 2025.

Instructure Holdings has completed its all-cash acquisition by KKR and Dragoneer for $23.60 per share, leading to its delisting from the NYSE.

Dogwood Therapeutics completed a $12.5 million offering of common stock and warrants, with pre-funded warrants immediately exercisable, while also terminating its ATM program.

OLB Group completed a private placement of pre-funded and common warrants, generating $3.0 million in gross proceeds and creating substantial future share dilution.

Duos Technologies Group is raising approximately $55 million through an offering of common stock and pre-funded warrants, which will significantly increase its share count.

Worksport completed two registered direct offerings, issuing common stock and warrants for total gross proceeds of approximately $722,870, leading to immediate and potential future dilution.

Pyxis Oncology is raising $50 million through a private placement of common stock and warrants, with potential for an additional $64 million from warrant exercise.

Bone Biologics Corp completed a private offering of pre-funded warrants and common stock warrants, raising $2.7 million in net proceeds but creating substantial potential future dilution.

S&W Seed Company announced its decision to voluntarily delist its common stock from Nasdaq and deregister with the SEC, citing financial burdens and likely future non-compliance.

LuxUrban Hotels Inc. received a delisting determination from Nasdaq due to its low stock bid price and failure to timely file its quarterly report, but plans to appeal by August 30, 2024.

ChampionX Corp is filing a Form 25-NSE to delist its Common Stock from the Nasdaq.

Units are delisting as they separate into individual shares and warrants.

Company filing to remove common stock from exchange; reason unclear.

Ribbon Acquisition Corp. shareholders will vote on amending the trust agreement to adjust monthly extension contributions, impacting the SPAC's deadline.

Advantage Solutions Inc. shareholders will vote on a reverse stock split to potentially regain compliance with listing standards.

SAB Biotherapeutics shareholders will vote on a proposal to issue over 19.99% of outstanding stock and approve an equity plan amendment.